Home - AOP Orphan

By selecting a country, you will see contents with local focus. Contents that are not available in the local language, will be shown in English.

Healthcare Professionals

Please log in for special information and services

- Our Company
  
  We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.
  About Our Company
- Rare Diseases And Symptoms
  
  We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.
  About Rare Diseases And Symptoms
  - HematoOncology
  - Cardiology & Pulmonology
    - Pulmonary arterial hypertension
  - Neurology & Metabolic Disorders
- Individual Treatments
  
  Our strategic goal at AOP Orphan is to constantly deliver new treatment options for the patients with rare disease. Learn more about the current product portfolio and countries' availability here.
  About Individual Treatments
  - HematoOncology
  - Cardiology & Pulmonology
    - TRISUVA®
  - Neurology & Metabolic Disorders
- Join Us
  
  Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.
  About Join Us
  - HR Team & Contacts
  - Jobs

COMPANY GROWTH

"I am proud to announce that AOP Orphan took over the health care companies AMOMED and SciPharm!“

Andreas Steiner | CEO | CHAIRMAN OF THE BOARD

PULMONARY ARTERIAL HYPERTENSION

"The time taken to establish the correct diagnosis is on average about 14 months."

POLYCYTHAEMIA VERA

“I found various means of helping myself and would like to share this experience with other persons.”

NARCOLEPSY WITH OR WITHOUT CATAPLEXY

"The moment, one suspects narcolepsy, the person must be referred to a sleep laboratory."

News

Meet Us Globally

Meet Us in Austria

Science & Innovation

From the Concept to the Drug

AOP Orphan headquarters team in Vienna covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.

More on the global website

CONNECTED WORLDWIDE

Partnering

Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe. Find out more about the cooperation opportunities with AOP Orphan using the link below.

More on the global website

Join Us

Join AOP Orphan

AOP Orphan team develops, investigates and provides therapy options for patients with rare diseases – commitment and appreciation are the essence of our cooperative work.

More on the global website